SP1 and glioma: Sp1, Sp3 and Sp4 are overexpressed in many different cancer cell lines [18, 19] and high expression of Sp1 in tumors is a negative prognostic factor for breast, pancreatic, gastric, glioma, prostate and lung cancer patients' survival [20–26].